Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents

Peter J. Gergen, Stephen J. Teach, Herman E. Mitchell, Robert F. Freishtat, Agustin Calatroni, Elizabeth Matsui, Meyer Kattan, Gordon R. Bloomberg, Andrew H. Liu, Carolyn Kercsmar, George O'Connor, Jacqueline Pongracic, Yadira Rivera-Sanchez, Wayne J Morgan, Christine A. Sorkness, Neil Binkley, William Busse

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: Decreased 25-hydroxyvitamin D [25(OH)D] concentrations have been associated with an increased prevalence and severity of asthma and a lower response to inhaled corticosteroids. Objective: The objective was to determine the association between serum 25(OH)D concentrations and asthma prevalence, severity, and response to asthma treatment. Design: Secondary analyses were conducted in 2 samples of adolescents 12-20 y of age: 1) NHANES 2001-2006 (n = 6487), a cross-sectional nationally representative sample of the US population, and 2) a cohort of inner-city adolescents with asthma managed prospectively for 46 wk with guidelines-based therapy in the Asthma Control Evaluation (ACE; n = 226) trial. Results: Mean (±SD) serum 25(OH)D concentrations in the NHANES and ACE samples were lower in African Americans than in non-African Americans (NHANES: 14.9 ± 6.5 compared with 23.0 ± 8.4 ng/mL, P < 0.0001; ACE: 11.2 ± 6.9 compared with 15.8 ± 7.1 ng/mL, P < 0.0001). In the NHANES sample, mean concentrations did not differ between participants without and with asthma (African Americans: 14.9 ± 6.4 compared with 15.0 ± 6.6 ng/mL, respectively, P = 0.87; non-African Americans: 23.0 ± 8.5 compared with 23.6 ± 8.2 ng/mL, respectively, P = 0.16). In the ACE models that used either a predefined cutoff (<20 ng/mL) or linear regression, 25(OH)D concentrations showed either no relation or minor contradictory correlations with indicators of asthma severity, treatment requirements, spirometry, or atopy/inflammation. Conclusion: In 2 samples of adolescents, overall serum 25(OH)D concentrations were low and were not consistently associated with the presence of asthma, multiple asthma characteristics, asthma morbidity, or response to treatment. The ACE trial was registered at clinicaltrials. gov as NCT0011441.

Original languageEnglish (US)
Pages (from-to)1228-1234
Number of pages7
JournalAmerican Journal of Clinical Nutrition
Volume97
Issue number6
DOIs
StatePublished - Jun 1 2013

Fingerprint

Asthma
Serum
Nutrition Surveys
African Americans
25-hydroxyvitamin D
Spirometry
Therapeutics
Linear Models
Adrenal Cortex Hormones
Guidelines
Inflammation
Morbidity
Population

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Gergen, P. J., Teach, S. J., Mitchell, H. E., Freishtat, R. F., Calatroni, A., Matsui, E., ... Busse, W. (2013). Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents. American Journal of Clinical Nutrition, 97(6), 1228-1234. https://doi.org/10.3945/ajcn.112.046961

Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents. / Gergen, Peter J.; Teach, Stephen J.; Mitchell, Herman E.; Freishtat, Robert F.; Calatroni, Agustin; Matsui, Elizabeth; Kattan, Meyer; Bloomberg, Gordon R.; Liu, Andrew H.; Kercsmar, Carolyn; O'Connor, George; Pongracic, Jacqueline; Rivera-Sanchez, Yadira; Morgan, Wayne J; Sorkness, Christine A.; Binkley, Neil; Busse, William.

In: American Journal of Clinical Nutrition, Vol. 97, No. 6, 01.06.2013, p. 1228-1234.

Research output: Contribution to journalArticle

Gergen, PJ, Teach, SJ, Mitchell, HE, Freishtat, RF, Calatroni, A, Matsui, E, Kattan, M, Bloomberg, GR, Liu, AH, Kercsmar, C, O'Connor, G, Pongracic, J, Rivera-Sanchez, Y, Morgan, WJ, Sorkness, CA, Binkley, N & Busse, W 2013, 'Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents', American Journal of Clinical Nutrition, vol. 97, no. 6, pp. 1228-1234. https://doi.org/10.3945/ajcn.112.046961
Gergen, Peter J. ; Teach, Stephen J. ; Mitchell, Herman E. ; Freishtat, Robert F. ; Calatroni, Agustin ; Matsui, Elizabeth ; Kattan, Meyer ; Bloomberg, Gordon R. ; Liu, Andrew H. ; Kercsmar, Carolyn ; O'Connor, George ; Pongracic, Jacqueline ; Rivera-Sanchez, Yadira ; Morgan, Wayne J ; Sorkness, Christine A. ; Binkley, Neil ; Busse, William. / Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents. In: American Journal of Clinical Nutrition. 2013 ; Vol. 97, No. 6. pp. 1228-1234.
@article{e99cbe5be52d446e9d86fd91b81a9f9e,
title = "Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents",
abstract = "Background: Decreased 25-hydroxyvitamin D [25(OH)D] concentrations have been associated with an increased prevalence and severity of asthma and a lower response to inhaled corticosteroids. Objective: The objective was to determine the association between serum 25(OH)D concentrations and asthma prevalence, severity, and response to asthma treatment. Design: Secondary analyses were conducted in 2 samples of adolescents 12-20 y of age: 1) NHANES 2001-2006 (n = 6487), a cross-sectional nationally representative sample of the US population, and 2) a cohort of inner-city adolescents with asthma managed prospectively for 46 wk with guidelines-based therapy in the Asthma Control Evaluation (ACE; n = 226) trial. Results: Mean (±SD) serum 25(OH)D concentrations in the NHANES and ACE samples were lower in African Americans than in non-African Americans (NHANES: 14.9 ± 6.5 compared with 23.0 ± 8.4 ng/mL, P < 0.0001; ACE: 11.2 ± 6.9 compared with 15.8 ± 7.1 ng/mL, P < 0.0001). In the NHANES sample, mean concentrations did not differ between participants without and with asthma (African Americans: 14.9 ± 6.4 compared with 15.0 ± 6.6 ng/mL, respectively, P = 0.87; non-African Americans: 23.0 ± 8.5 compared with 23.6 ± 8.2 ng/mL, respectively, P = 0.16). In the ACE models that used either a predefined cutoff (<20 ng/mL) or linear regression, 25(OH)D concentrations showed either no relation or minor contradictory correlations with indicators of asthma severity, treatment requirements, spirometry, or atopy/inflammation. Conclusion: In 2 samples of adolescents, overall serum 25(OH)D concentrations were low and were not consistently associated with the presence of asthma, multiple asthma characteristics, asthma morbidity, or response to treatment. The ACE trial was registered at clinicaltrials. gov as NCT0011441.",
author = "Gergen, {Peter J.} and Teach, {Stephen J.} and Mitchell, {Herman E.} and Freishtat, {Robert F.} and Agustin Calatroni and Elizabeth Matsui and Meyer Kattan and Bloomberg, {Gordon R.} and Liu, {Andrew H.} and Carolyn Kercsmar and George O'Connor and Jacqueline Pongracic and Yadira Rivera-Sanchez and Morgan, {Wayne J} and Sorkness, {Christine A.} and Neil Binkley and William Busse",
year = "2013",
month = "6",
day = "1",
doi = "10.3945/ajcn.112.046961",
language = "English (US)",
volume = "97",
pages = "1228--1234",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "6",

}

TY - JOUR

T1 - Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents

AU - Gergen, Peter J.

AU - Teach, Stephen J.

AU - Mitchell, Herman E.

AU - Freishtat, Robert F.

AU - Calatroni, Agustin

AU - Matsui, Elizabeth

AU - Kattan, Meyer

AU - Bloomberg, Gordon R.

AU - Liu, Andrew H.

AU - Kercsmar, Carolyn

AU - O'Connor, George

AU - Pongracic, Jacqueline

AU - Rivera-Sanchez, Yadira

AU - Morgan, Wayne J

AU - Sorkness, Christine A.

AU - Binkley, Neil

AU - Busse, William

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Background: Decreased 25-hydroxyvitamin D [25(OH)D] concentrations have been associated with an increased prevalence and severity of asthma and a lower response to inhaled corticosteroids. Objective: The objective was to determine the association between serum 25(OH)D concentrations and asthma prevalence, severity, and response to asthma treatment. Design: Secondary analyses were conducted in 2 samples of adolescents 12-20 y of age: 1) NHANES 2001-2006 (n = 6487), a cross-sectional nationally representative sample of the US population, and 2) a cohort of inner-city adolescents with asthma managed prospectively for 46 wk with guidelines-based therapy in the Asthma Control Evaluation (ACE; n = 226) trial. Results: Mean (±SD) serum 25(OH)D concentrations in the NHANES and ACE samples were lower in African Americans than in non-African Americans (NHANES: 14.9 ± 6.5 compared with 23.0 ± 8.4 ng/mL, P < 0.0001; ACE: 11.2 ± 6.9 compared with 15.8 ± 7.1 ng/mL, P < 0.0001). In the NHANES sample, mean concentrations did not differ between participants without and with asthma (African Americans: 14.9 ± 6.4 compared with 15.0 ± 6.6 ng/mL, respectively, P = 0.87; non-African Americans: 23.0 ± 8.5 compared with 23.6 ± 8.2 ng/mL, respectively, P = 0.16). In the ACE models that used either a predefined cutoff (<20 ng/mL) or linear regression, 25(OH)D concentrations showed either no relation or minor contradictory correlations with indicators of asthma severity, treatment requirements, spirometry, or atopy/inflammation. Conclusion: In 2 samples of adolescents, overall serum 25(OH)D concentrations were low and were not consistently associated with the presence of asthma, multiple asthma characteristics, asthma morbidity, or response to treatment. The ACE trial was registered at clinicaltrials. gov as NCT0011441.

AB - Background: Decreased 25-hydroxyvitamin D [25(OH)D] concentrations have been associated with an increased prevalence and severity of asthma and a lower response to inhaled corticosteroids. Objective: The objective was to determine the association between serum 25(OH)D concentrations and asthma prevalence, severity, and response to asthma treatment. Design: Secondary analyses were conducted in 2 samples of adolescents 12-20 y of age: 1) NHANES 2001-2006 (n = 6487), a cross-sectional nationally representative sample of the US population, and 2) a cohort of inner-city adolescents with asthma managed prospectively for 46 wk with guidelines-based therapy in the Asthma Control Evaluation (ACE; n = 226) trial. Results: Mean (±SD) serum 25(OH)D concentrations in the NHANES and ACE samples were lower in African Americans than in non-African Americans (NHANES: 14.9 ± 6.5 compared with 23.0 ± 8.4 ng/mL, P < 0.0001; ACE: 11.2 ± 6.9 compared with 15.8 ± 7.1 ng/mL, P < 0.0001). In the NHANES sample, mean concentrations did not differ between participants without and with asthma (African Americans: 14.9 ± 6.4 compared with 15.0 ± 6.6 ng/mL, respectively, P = 0.87; non-African Americans: 23.0 ± 8.5 compared with 23.6 ± 8.2 ng/mL, respectively, P = 0.16). In the ACE models that used either a predefined cutoff (<20 ng/mL) or linear regression, 25(OH)D concentrations showed either no relation or minor contradictory correlations with indicators of asthma severity, treatment requirements, spirometry, or atopy/inflammation. Conclusion: In 2 samples of adolescents, overall serum 25(OH)D concentrations were low and were not consistently associated with the presence of asthma, multiple asthma characteristics, asthma morbidity, or response to treatment. The ACE trial was registered at clinicaltrials. gov as NCT0011441.

UR - http://www.scopus.com/inward/record.url?scp=84878422234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878422234&partnerID=8YFLogxK

U2 - 10.3945/ajcn.112.046961

DO - 10.3945/ajcn.112.046961

M3 - Article

C2 - 23595876

AN - SCOPUS:84878422234

VL - 97

SP - 1228

EP - 1234

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 6

ER -